Surmodics Quick Ratio 2006-2019 | SRDX

Historical quick ratio values for Surmodics (SRDX) over the last 10 years.
Surmodics Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2019-06-30 $0.07B $0.02B 3.80
2019-03-31 $0.07B $0.02B 3.30
2018-12-31 $0.07B $0.02B 3.26
2018-09-30 $0.08B $0.04B 2.21
2018-06-30 $0.08B $0.03B 2.37
2018-03-31 $0.08B $0.03B 2.26
2017-12-31 $0.06B $0.02B 2.87
2017-09-30 $0.06B $0.01B 5.85
2017-06-30 $0.05B $0.01B 7.18
2017-03-31 $0.06B $0.01B 8.17
2016-12-31 $0.05B $0.01B 8.96
2016-09-30 $0.06B $0.01B 5.43
2016-06-30 $0.05B $0.01B 6.29
2016-03-31 $0.05B $0.01B 5.82
2015-12-31 $0.05B $0.01B 8.91
2015-09-30 $0.07B $0.01B 13.79
2015-06-30 $0.06B $0.00B 14.54
2015-03-31 $0.06B $0.00B 15.92
2014-12-31 $0.04B $0.00B 10.23
2014-09-30 $0.05B $0.00B 12.90
2014-06-30 $0.05B $0.00B 11.64
2014-03-31 $0.04B $0.00B 12.92
2013-12-31 $0.03B $0.00B 6.72
2013-09-30 $0.03B $0.01B 5.43
2013-06-30 $0.04B $0.00B 9.25
2013-03-31 $0.04B $0.00B 12.23
2012-12-31 $0.04B $0.01B 5.29
2012-09-30 $0.04B $0.01B 5.28
2012-06-30 $0.09B $0.01B 16.00
2012-03-31 $0.08B $0.01B 14.17
2011-12-31 $0.08B $0.01B 12.10
2011-09-30 $0.05B $0.01B 4.66
2011-06-30 $0.05B $0.01B 6.23
2011-03-31 $0.04B $0.01B 3.76
2010-12-31 $0.04B $0.01B 4.11
2010-09-30 $0.03B $0.01B 4.50
2010-06-30 $0.04B $0.01B 4.72
2010-03-31 $0.04B $0.01B 5.00
2009-12-31 $0.04B $0.01B 5.40
2009-09-30 $0.03B $0.01B 4.22
2009-06-30 $0.04B $0.01B 4.01
2009-03-31 $0.03B $0.02B 1.99
2008-12-31 $0.04B $0.02B 2.05
2008-09-30 $0.04B $0.01B 3.50
2008-06-30 $0.05B $0.01B 3.91
2008-03-31 $0.06B $0.02B 3.88
2007-12-31 $0.05B $0.01B 3.45
2007-09-30 $0.05B $0.02B 2.29
2007-06-30 $0.08B $0.01B 11.14
2007-03-31 $0.05B $0.01B 8.60
2006-12-31 $0.07B $0.01B 6.46
2006-09-30 $0.08B $0.01B 8.36
2006-06-30 $0.07B $0.01B 11.50
2006-03-31 $0.06B $0.01B 9.58
2005-12-31 $0.05B $0.00B 12.28
2005-09-30 $0.04B $0.01B 7.91
2005-06-30 $0.03B $0.01B 5.12
2005-03-31 $0.02B $0.01B 4.72
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.573B $0.081B
SurModics, Inc. is a leading provider of surface modification technologies in the areas of biocompatibility, site specific drug delivery, biological cell encapsulation, and medical diagnostics. SurModics partners with the world's foremost medical device, pharmaceutical and life science companies to bring innovation together for better patient outcomes. Recent collaborative efforts include the implementation of SurModics' Bravo drug delivery polymer matrix as a key component of the first-to-market drug-eluting coronary stent. SurModics is also active in the ophthalmology market with a sustained drug delivery system that is currently in human trials for treatment of retinal disease. A significant portion of SurModics' revenue is generated by royalties earned from the sale of our customers' commercial products.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $144.337B 20.26
Abbott Laboratories (ABT) United States $140.738B 26.45
Stryker (SYK) United States $79.987B 27.66
Boston Scientific (BSX) United States $53.253B 25.83
Baxter (BAX) United States $44.944B 27.25
EssilorLuxottica Societe Anonyme (ESLOY) France $32.375B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.013B 17.93
Coloplast (CLPBY) Denmark $24.818B 39.62
Lonza Group Ag (LZAGY) Switzerland $24.634B 0.00
Terumo (TRUMY) Japan $23.332B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $20.543B 0.00
ResMed (RMD) United States $18.641B 35.52
Sunny Optical Technology (SNPTF) China $16.343B 0.00
Bio-Rad Laboratories (BIO) United States $9.871B 52.91
Insulet (PODD) United States $9.245B 547.82
Perrigo (PRGO) Ireland $7.271B 13.39
Canopy Growth (CGC) Canada $6.759B 0.00
Hill-Rom Holdings (HRC) United States $6.636B 19.78
Haemonetics (HAE) United States $6.525B 49.24
William Demant Holdings (WILYY) Denmark $5.988B 0.00
GN STORE NORD (GNNDY) Denmark $5.322B 27.49
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Aurora Cannabis (ACB) Canada $3.786B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.537B 0.00
Neogen (NEOG) United States $3.350B 56.05
NuVasive (NUVA) United States $3.316B 26.44
ICU Medical (ICUI) United States $3.170B 20.56
Quidel (QDEL) United States $2.389B 23.72
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.290B 0.00
Agios Pharmaceuticals (AGIO) United States $1.917B 0.00
National Vision Holdings (EYE) United States $1.879B 40.56
Cardiovascular Systems (CSII) United States $1.641B 0.00
Aphria (APHA) $1.187B 0.00
VAREX IMAGING (VREX) United States $1.080B 24.88
AtriCure (ATRC) United States $1.009B 0.00
Phibro Animal Health (PAHC) United States $0.855B 13.90
Eagle Pharmaceuticals (EGRX) United States $0.821B 20.92
Omeros (OMER) United States $0.756B 0.00
NanoString Technologies (NSTG) United States $0.753B 0.00
Lantheus Holdings (LNTH) United States $0.737B 19.38
PetIQ (PETQ) United States $0.712B 16.81
Cerus (CERS) United States $0.630B 0.00
LeMaitre Vascular (LMAT) United States $0.622B 36.86
MacroGenics (MGNX) United States $0.556B 0.00
Quanterix (QTRX) United States $0.547B 0.00
TG Therapeutics (TGTX) United States $0.493B 0.00
OraSure Technologies (OSUR) United States $0.475B 22.00
Owens & Minor (OMI) United States $0.399B 11.94
Meridian Bioscience (VIVO) United States $0.382B 11.93
Zynex (ZYXI) United States $0.379B 40.31
Utah Medical Products (UTMD) United States $0.347B 25.45
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.311B 0.00
BioLife Solutions (BLFS) United States $0.309B 95.06
United Health Products (UEEC) United States $0.245B 0.00
Bovie Medical (APYX) United States $0.235B 0.00
Vapotherm (VAPO) United States $0.175B 0.00
Rockwell Medical (RMTI) United States $0.160B 0.00
Cytosorbents (CTSO) United States $0.151B 0.00
Female Health (VERU) United States $0.135B 0.00
Fonar (FONR) United States $0.128B 9.00
InfuSystems Holdings (INFU) United States $0.128B 0.00
Chembio Diagnostics (CEMI) United States $0.097B 0.00
Chimerix (CMRX) United States $0.095B 0.00
United-Guardian (UG) United States $0.085B 20.14
Nephros (NEPH) United States $0.071B 0.00
MTech Acquisition (KERN) United States $0.063B 0.00
MRI Interventions (MRIC) United States $0.056B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Surface Oncology (SURF) United States $0.034B 0.00
Senestech (SNES) United States $0.024B 0.00
Trinity Biotech (TRIB) Ireland $0.023B 0.00
GUARDION HEALTH (GHSI) United States $0.021B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Myomo (MYO) United States $0.010B 0.00
Capricor Therapeutics (CAPR) United States $0.009B 0.00
Valeritas Holdings (VLRX) United States $0.006B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00